Ceftar S 250mg/500mg Injection
By Ceftar S
Rx
1 Injection in a Vial

Composition
Ceftriaxone(250mg) + Sulbactam(500mg)

Manufacturer - Nova Indus Pharmaceuticals
No. 62, Radha Krishna, Nirmal Complex, Power House Road Babyal, Babyal, Ambala-133005, Haryana, India

Expires on or after
August, 2025

liver
Ceftar S 250mg/500mg Injection should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of Ceftar S 250mg/500mg Injection in these patients, so it's important to seek advice from your healthcare provider. However, dose adjustment of Ceftar S 250mg/500mg Injection is not advised for individuals with mild to moderate liver disease. If you have any concerns about using this medication due to liver issues, consult your doctor for personalized guidance.

kidney
Consult your doctor about Ceftar S 250mg/500mg Injection use in kidney disease cases due to limited available information.

alcohol
When taking Ceftar S 250mg/500mg Injection, it is safe to consume alcohol as it does not result in any harmful side effects.

driving
When taking Ceftar S 250mg/500mg Injection, be cautious as it may reduce alertness, impact vision, and cause drowsiness and dizziness. Refrain from driving if experiencing these effects.

pregnancy
Ceftar S 250mg/500mg Injection is likely safe during pregnancy based on animal studies, but human data is limited.

breastfeeding
During breastfeeding, caution is advised when using Ceftar S 250mg/500mg Injection. It is recommended to suspend breastfeeding until the mother's treatment is finished and the drug is no longer in her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹85
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025